Search details
1.
Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer.
N Engl J Med
; 389(7): 612-619, 2023 Aug 17.
Article
in English
| MEDLINE | ID: mdl-37585627
2.
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.
Br J Cancer
; 128(12): 2283-2294, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37076566
3.
Ki67 assessment protocol as an integral biomarker for avoiding radiotherapy in the LUMINA breast cancer trial.
Histopathology
; 83(6): 903-911, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37609778
4.
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study.
Mod Pathol
; 35(10): 1362-1369, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35729220
5.
An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer.
Mod Pathol
; 32(1): 59-69, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30143750
6.
Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.
Histopathology
; 75(2): 225-235, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-31017314
7.
A role of SIPL1/SHARPIN in promoting resistance to hormone therapy in breast cancer.
Biochim Biophys Acta Mol Basis Dis
; 1864(3): 735-745, 2018 Mar.
Article
in English
| MEDLINE | ID: mdl-29248549
8.
Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours.
Breast Cancer Res
; 19(1): 76, 2017 Jul 01.
Article
in English
| MEDLINE | ID: mdl-28668076
9.
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.
Breast Cancer Res Treat
; 161(1): 117-134, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27796716
10.
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.
Mod Pathol
; 29(10): 1155-64, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27363491
11.
The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures.
BMC Cancer
; 16: 555, 2016 07 28.
Article
in English
| MEDLINE | ID: mdl-27469239
12.
Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications.
Breast Cancer Res Treat
; 149(1): 293-301, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25542270
13.
An international study to increase concordance in Ki67 scoring.
Mod Pathol
; 28(6): 778-86, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25698062
14.
The Significance of Thyroid Hormone Receptors in Breast Cancer: A Hypothesis-Generating Narrative Review.
Curr Oncol
; 31(5): 2364-2375, 2024 04 23.
Article
in English
| MEDLINE | ID: mdl-38785457
15.
Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers.
Breast Cancer Res Treat
; 140(1): 195-205, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23813303
16.
Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force.
Curr Oncol
; 30(3): 3079-3090, 2023 03 06.
Article
in English
| MEDLINE | ID: mdl-36975446
17.
A role for the TGFbeta-Par6 polarity pathway in breast cancer progression.
Proc Natl Acad Sci U S A
; 106(33): 14028-33, 2009 Aug 18.
Article
in English
| MEDLINE | ID: mdl-19667198
18.
EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry.
Breast Cancer Res Treat
; 127(3): 831-9, 2011 Jun.
Article
in English
| MEDLINE | ID: mdl-21327470
19.
Amplification of the prolactin receptor gene in mammary lobular neoplasia.
Breast Cancer Res Treat
; 128(1): 31-40, 2011 Jul.
Article
in English
| MEDLINE | ID: mdl-20658264
20.
Predictors of Outcome in Mammary Adenoid Cystic Carcinoma: A Multi-Institutional Study.
Am J Surg Pathol
; 44(2): 214-223, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31567278